| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 2,619 | 2,428 | 2,658 | 2,698 | | Cost of Revenue | 1,705 | 1,643 | 1,354 | 2,153 | | | Gross Profit | 914 | 785 | 1,304 | 545 | | | Operating Expenses | | Research Development | 22,147 | 24,205 | 42,620 | 52,729 | | Selling General and Administrative | 5,423 | 5,660 | 7,642 | 8,597 | | Non Recurring |
-
| 3,324 |
-
|
-
| | Others | 582 | 573 | 566 | 1,161 | | | | Total Operating Expenses |
-
| 33,762 |
-
|
-
| | | | Operating Income or Loss | (27,238) | (32,977) | (49,524) | (61,942) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (258) | (3,071) | 627 | 1,037 | | Earnings Before Interest And Taxes | (27,496) | (36,048) | (48,897) | (60,905) | | Interest Expense | 7,339 | 1,935 | 1,717 | 1,308 | | Income Before Tax | (34,835) | (37,983) | (50,614) | (62,213) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (37,314) | (37,983) | (50,614) | (62,213) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (34,835) | (37,983) | (50,614) | (62,213) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| (268) | | | Net Income Applicable To Common Shares | ($34,835) | ($37,983) | ($50,614) | ($62,481) |
|
0.29% Nasdaq 
Income Statement
